H1N1 (ENCO) Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial Win; Company Successful with its Strategic Focus on Vaccines and Oncology Trials 9/9/2009
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.